158 related articles for article (PubMed ID: 443860)
21. In vitro lymphocyte reactivity to soluble tumor extracts in Sinclair melanoma swine.
Aultman MD; Hook RR
Int J Cancer; 1979 Nov; 24(5):673-8. PubMed ID: 528082
[No Abstract] [Full Text] [Related]
22. Inhibition of leukocyte migration in agarose by KCl extracts of human melanoma cell line grown in serum-free medium.
Boddie AW; Urist MM; Chee DO; Holmes EC; Morton DL
Int J Cancer; 1975 Dec; 16(6):1035-41. PubMed ID: 1201872
[TBL] [Abstract][Full Text] [Related]
23. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
24. Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of immunologic responses.
Cassel WA; Murray DR; Torbin AH; Olkowski ZL; Moore ME
Cancer; 1977 Aug; 40(2):672-9. PubMed ID: 196739
[TBL] [Abstract][Full Text] [Related]
25. Reactivity of gastric cancer patients in leucocyte migration inhibition tests to 3M KCl extracts from gastric tumor.
Kojima O; Oh A; Kitagawa N; Uehara Y; Nishioka B; Fujita Y; Majima S
Jpn J Surg; 1981; 11(6):413-21. PubMed ID: 7035728
[TBL] [Abstract][Full Text] [Related]
26. Long-term spontaneous regression of malignant melanoma with visceral metastases. Report of a case with immunologic profile.
Bulkley GB; Cohen MH; Banks PM; Char DH; Ketcham AS
Cancer; 1975 Aug; 36(2):485-94. PubMed ID: 1157014
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy for human malignant melanoma.
Kopf AW
South Med J; 1975 Apr; 68(4):495-503. PubMed ID: 1124416
[TBL] [Abstract][Full Text] [Related]
28. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
Kokoschka EM
Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
[No Abstract] [Full Text] [Related]
29. Production and characterization of xenogeneic antisera to tumor-associated antigen(s).
Gupta RK; Silver HK; Morton DL
J Surg Oncol; 1980; 13(1):75-89. PubMed ID: 6153230
[TBL] [Abstract][Full Text] [Related]
30. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma.
Douwes FR; Spellmann HJ; Mross K; Wolfrum DI
Oncology; 1978; 35(4):163-7. PubMed ID: 81476
[TBL] [Abstract][Full Text] [Related]
31. [Immunology of melanoma].
Vanwijck R; Bernheim JL; Lejeune FJ
Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
[No Abstract] [Full Text] [Related]
32. [Immunology of malignant melanoma].
Misgeld V
Hautarzt; 1973 Dec; 24(12):511-9. PubMed ID: 4599321
[No Abstract] [Full Text] [Related]
33. Demonstration of cellular immunity to tumor-specific antigens of malignant melanoma in hamsters by inhibition of macrophage migration.
Henderson WR; Fukuyama K; Epstein WL; Spitler LE
J Invest Dermatol; 1972 Apr; 58(4):229-32. PubMed ID: 5020976
[No Abstract] [Full Text] [Related]
34. Sandwich radioimmunoassay using single monoclonal antibody that detects minute amounts of melanoma antigens from various mammalian species.
Wakabayashi S; Okamoto S; Taniguchi M
Gan; 1984 May; 75(5):427-32. PubMed ID: 6204903
[TBL] [Abstract][Full Text] [Related]
35. [Tissue extracts of malignant human lymphomas in the leukocyte migration test].
Schwalbe P; Arndt D; Müller-Hermelink HK
Acta Biol Med Ger; 1978; 37(7):1105-12. PubMed ID: 747042
[TBL] [Abstract][Full Text] [Related]
36. Purification and immunologic evaluation of human melnoma-associated antigens.
McCabe RP; Ferrone S; Pellegrino MA; Kern DH; Holmes EC; Reisfeld RA
J Natl Cancer Inst; 1978 Apr; 60(4):773-7. PubMed ID: 75978
[TBL] [Abstract][Full Text] [Related]
37. Vaccination for malignant melanoma: recent developments.
Jäger D; Jäger E; Knuth A
Oncology; 2001; 60(1):1-7. PubMed ID: 11150901
[TBL] [Abstract][Full Text] [Related]
38. Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment.
Seigler HF; Shingleton WW; Pickrell KL
Plast Reconstr Surg; 1975 Mar; 55(3):294-8. PubMed ID: 1118487
[TBL] [Abstract][Full Text] [Related]
39. Cell-mediated immunity in malignant melanoma.
Cochran AJ; Jehn UW; Gothoskar BP
Lancet; 1972 Jun; 1(7764):1340-1. PubMed ID: 4113434
[No Abstract] [Full Text] [Related]
40. Simian virus 40 in a human cancer.
Soriano F; Shelburne CE; Gökcen M
Nature; 1974 May; 249(456):421-4. PubMed ID: 4365941
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
